GovChime
Notice ID: 123f802ca5024198be3510423842d9baAward NoticeAwarded

6505--Influenza Virus Vaccine 2025-2026 Flu Season; Awarded Line Items 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, and 12

Awarded on November 20, 2024. Full description on SAM.gov.

Awarded tounder 36E79725D0006 (source: SAM.gov award notice)• $51.6M

Overview

Posted
November 20, 2024
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Veterans Affairs

Notice details

Last updated
Nov 13, 2025
Award date
Nov 20, 2024
Award amount (SAM.gov award notice)
$51.6M

Identifiers

Solicitation number
36E79724R0031
Notice ID
123f802ca5024198be3510423842d9ba
Award number (PIID)
36E79725D0006

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79724R0031 for an unrestrictive procurement for the Influenza Virus Vaccine for the Department of Veterans Affairs (VA) to include State Veteran Homes option 2 (SVH2 s), Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center (FHCC) for the 2025-2026 influenza season. Evaluation and award will be made by solicitation line item for VA, BOP, IHS, and FHCC requirements. Offerors are not required to submit an offer for every line item; however, the offeror must offer the full quantity for each line item offered. Additionally, all offered line items for a single presentation must be offered at the same unit price. Please note that the final offered price must include the Cost Recovery Fee (CRF) and Federal Excise Tax (FET). Orders will be placed by and delivered to VA, SVH2, BOP, and IHS facilities throughout the United States, the Philippines and Puerto Rico. The contractor(s) will be required to deliver the vaccine Free On Board (FOB) Destination to Government facilities within the U.S., Philippines, and Puerto Rico. The first shipment of product ordered must be at least 50% of each individual facility s ordered quantity and must be delivered between August 15, 2025, and September 15, 2025. The second shipment must be for the remaining individual facility s entire ordered quantity and must be delivered between September 16, 2025, and October 15, 2025. FHCC shall receive 100% of the awarded quantities between August 15, 2025, and September 15, 2025. Solicitation number 36E79724R0031 is estimated to be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 18, 2024, with a closing date of October 2, 2024. ESTIMATED ANNUAL REQUIREMENTS BY AGENCY PRESENTATION DESCRIPTION PACKAGE TYPE VA EST ANNUAL USAGE BOP EST ANNUAL USAGE IHS EST ANNUAL USAGE FHCC EST ANNUAL USAGE TOTAL ESTIMATED ANNUAL USAGE 1 Influenza Virus Vaccine: 10 dose multiple dose vial, or 10 - 0.5ml Vials, Quadrivalent; 2025-2026 Influenza season; for persons 6 months, latex free. VIAL (10 doses/vial or box of 10 individual vials) 6,500 2,033 2,676 0 11,209 2 Influenza Virus Vaccine: Pre-filled single dose syringes with plunger and Luer lock needle attachment, Quadrivalent; 2025-2026 Influenza season; for persons 36 months. SYRINGE (Box of 10) 120,000 3,556 29,198 750 153,504 3 Influenza Virus Vaccine: Pre-filled single dose syringe with plunger and Luer lock needle attachment, Quadrivalent or Trivalent; 2025-2026 Influenza season; must be specifically designed for persons 65 years and older as outlined by the CDC. SYRINGE (Box of 10) 120,000 236 11,637 400 132,273 4 Influenza Virus Vaccine: Pre-filled single dose syringe with plunger and Luer lock needle attachment, Quadrivalent; 2025-2026 Influenza season. Must be split virus vaccine (subvirion or purified surface antigen) that has been FDA approved and labeled with indications for administration to children 6 months - 35 months of age (pediatric), preservative free. SYRINGE (Box of 10) 0 0 1,462 0 1,462 Quadrivalent presentation is currently specified. However, this may change if the World Health Organization (WHO) recommends the Trivalent presentation for any of the dose types. If both presentations are recommended by WHO and offered commercially by the offeror/contract awardee, then the Quadrivalent presentation would be required.

Full description on SAM.gov

Award Overview

Award Number

36E79725D0006

Award Amount (SAM.gov award notice)

$51.6M

Award Date

Nov 20, 2024

Awardee

Awardee UEI

N6U7P2B9VHS5

Original Solicitation

Notice ID: 123f802ca5024198be3510423842d9ba

Posted Date: Nov 20, 2024

Original Response Deadline: Not specified

Task Orders Under This IDV

Top 10 by total obligated

10
  • 75H71125F80104
    SEQIRUS USA INC
    Department of Health and Human ServicesNAICS 325412
    $5.4MSigned Sep 11, 2025
  • 36C26025F0189
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $426.3KSigned Mar 25, 2025
  • 36C24625N0674
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $390.8KSigned Apr 1, 2025
  • 36C24525N0530
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $315.0KSigned Apr 3, 2025
  • 36C24625F0112
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $253.7KSigned Mar 26, 2025
  • 36C24525N0483
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $217.4KSigned Mar 19, 2025
  • 36C24525N0505
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $205.7KSigned Mar 25, 2025
  • 36C26025N0260
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $204.7KSigned Mar 19, 2025
  • 36C24525N0465
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $193.2KSigned Mar 20, 2025
  • 36C24625N0713
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $159.4KSigned Apr 7, 2025

More From This Vendor

Top 5 most recent

5
  • 36E79726D0010
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    —Signed Sep 1, 2026
  • 36F79724D0190
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    —Signed Aug 21, 2026
  • 36E79726D0010
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    —Signed Aug 11, 2026
  • 36F79724D0190
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    —Signed Jun 15, 2026
  • 36C24626N0645
    SEQIRUS USA INC
    Department of Veterans AffairsNAICS 325412
    $168.0KSigned Apr 14, 2026

Contacts

Documents

Showing 1 of 1 items

Document
Source
Agency
Posted Date
File Size
Actions
Award NoticeDepartment of Veterans AffairsNov 20, 2024-

Lifecycle

Solicitation:36E79724R0031
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

This opportunity has been awarded.

  1. Pre-SolicitationSep 11, 2024

    6505--Influenza Virus Vaccine (2025-2026 Flu Season)

    Notice 7a7a34dc648140e2bcb1693cc7a463ab on SAM.gov

  2. SolicitationSep 23, 2024

    6505--Influenza Virus Vaccine (2025-2026 Flu Season)

    Notice b3b8ecc590bf429c9ebe9672b17b45d5 on SAM.gov

  3. 2×
    AwardedCurrentNov 20, 2024

    6505--Influenza Virus Vaccine 2025-2026 Flu Season; Awarded Line Items 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, and 12

    Notice 123f802ca5024198be3510423842d9ba on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79727R0010 for an unrestricted procurement for Nitroglycerin Patches, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label. This product does not require unit of use packaging, as identified in the Schedule of Supplies. Patches must be boxed and must contain the bar code. The outside box as well as the patch must be barcoded. Solicitation #36E79727R0010 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 1, 2026, with a tentative closing date of December 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Jacob Werling. Questions can be e-mailed to Jacob.Werling@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION UNIT of USE PKG. SIZE (Patches per Box) TOTAL EST. ANNUAL USAGE (Boxes) 1 Nitroglycerin 0.1 mg Patch N 30 4,982 2 Nitroglycerin 0.2 mg Patch N 30 10,044 3 Nitroglycerin 0.4 mg Patch N 30 8,720 4 Nitroglycerin 0.6 mg Patch N 30 2,213
-Pre-Solicitation11/18/2026
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79727R0009 for an unrestricted procurement for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN CAP/TAB, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Solicitation #36E79727R0009 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 23, 2026, with a tentative closing date of January 13, 2027. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Bottles) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN CAP/TAB 120 829,230
-Pre-SolicitationOpen
Please see attached documents.
-Pre-Solicitation12/15/2026
Department of Veterans Affairs Pharmaceutical Prime Vendor 2028 Specialty Pharmacy RFI AMENDMENT 0002 The purpose of this amendment is to extend the response date for this Request for Information (RFI) from November 16, 2026, 11:00 AM Central Time to November 30, 2026, 11:00 AM Central Time. All other information in this notice, including Amendment 0001, remains unchanged.
-Market Research11/30/2026
-AwardedOpen

Additional Details

Solicitation Number

36E79724R0031

Archive Date

Jan 19, 2025

Office Address

HINES, IL, 60141